Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boguniewicz

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
Pediatric Dermatology|March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.
The Journal of Investigative Dermatology|November 25, 2011
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Donald Y M Leung, Nicholas M Rafaels, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
The British Journal of Dermatology|July 1, 2026
Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 yearElaine C Siegfried, Eulalia Baselga, Marlies de Graaf, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
The Journal of Allergy and Clinical Immunology|May 15, 2010
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Deguang Mu, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
Pediatric Dermatology|March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.
The Journal of Investigative Dermatology|November 25, 2011
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Donald Y M Leung, Nicholas M Rafaels, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
The British Journal of Dermatology|July 1, 2026
Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 yearElaine C Siegfried, Eulalia Baselga, Marlies de Graaf, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
The Journal of Allergy and Clinical Immunology|May 15, 2010
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Deguang Mu, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
Pageof 16